Since high altitude has been shown to alter lipid metabolism, the fasting lipid profiles and hormonal responses of eight human subjects were determined at sea level and during a 40-day hypobaric chamber study that simulated the ascent to Mt. Everest. The study, entitled Operation Everest II, was unique in that it examined the chronic effects of hypoxia without additional environmental stresses.
MATERIALS AND METHODS
During the course of Operation Everest II, six male test subjects (aged 21-31 yr) were decompressed from sea level (SL, 760 Torr) to 282 torr over a 40-day period. During the last week of the study, the subjects were exposed periodically to 240 Torr for additional testing at the simulated summit of Mt. Everest. Of the initial eight subjects, two subjects were unable to complete the study and their data are not included here. Operation Everest II was conducted in the hypobaric chamber at the U. S. Army Research
Institute of Environmental Medicine (USARIEM), in Natick, MA (50 m).
Complete details of Operation Everest II were published elsewhere (16).
During the study the cycling maximal oxygen uptake (102 max) of each subject was determined using a discontinuous protocol. Details of the non-invasive instrumentation and measurements taken during exercise are published elsewhere (13).
From the onset of the study at sea level and through the last day in the hypobaric chamber, the subjects consumed an ad libitum diet. The menus, food preparation, and dietary data collection were supervised by a registered dietician and complete details are described elsewhere (29). Briefly, the subjects selected three meals daily from menus consisting of approximately 3000 kcal/day distributed to provide 60% carbohydrate, 15% protein, and 25% fat in the diet. A variety of foods and non-alcoholic beverages were available for snacks. Foods were weighed before and after the meal and intakes were analyzed using the University of Massachusetts Nutrient Data Bank program. Gross fluid balance was determined by subtracting the urine output from the fluid intake. Each morning, the subjects were weighed after arising and voiding.
Before the subjects arose in the morning and while remaining in a supine 
S
For all subjects, total fluid intake exceeded total urine output, indicating that the subjects were not hypohydrated (29 Fasting plasma glucose concentrations were unchanged, averaging 4.87*0.05 mM throughout the study.
Plasma Hormone Concentrations
Insulin and Glucagon Concentrations. Prior to ascent, fasting-AM plasma insulin levels (Fig 3) The intake of dietary fat was in accordance with guidance established by the American Heart Association (ARA) recommending restriction of dietary fat intake to less than 30% of the total daily caloric consumption (15). At the higher altitudes, the percentage of kcal from fat was 33%, representing a significant increase over the pre-ascent daily fat caloric consumption of 25% (29). However, since the subjects consumed less total calories at the higher altitudes, the pre-ascent fat consumption was 784 kcal/day, a greater amount than the 590 kcal dietary fat/day at 282 Torr. Therefore, the slight alteration in dietary fat consumed during the study does not appear to be a major factor in the alteration of the plasma TG profile. Additionally, since Consumption of a diet low in saturated !ats and cholesterol over a three month time period caused an decrease in TC of 32mg/dl with no change in TG (33).
In the present study, the diet contained a moderate amount of cholesterol varying between approximately 300 and 500 mg/day, slightly more than the amount recommended for reduction of plasma TC levels. Additionall, for reduction of plasma TC levels, the ABA recommends maintenance of a dietary P:S ratio of approximately 1 (15) . In the present study, the subjects voluntarily consumed a diet with a P:S ratio consistently lower than 1 and continued to decrease the P:S ratio in their diet. Thus, the amount of cholesterol consumed in the diet coupled with the steady decrease in the P:S ratio could have resulted in increased plasma TC, rather than the decrease in TC observed in the present study.
Of additional concern would be the voluntary restriction of caloric intake upon reaching the higher altitudes. During actual ascent, mountaineers cite lack of water, environmental conditions and overall fatigue as reasons for limiting caloric intake and food consumption. These were not factors in the present study. The subjects had unlimited access to any type of food they requested. Also, the diets were nutritionally balanced with the goal to stimulate the subject's appetite and meet his caloric needs (29). Yet each subject lost significant amounts of LBM and body fat.
Loss of weight has been reported to decrease fasting blood TG levels.
(26).
Loss of approximately 11 kg in normal and hypertriglyceridemic individuals resulted in a decrease in plasma TG and TC levels (26). Also, weight loss is prescribed as a treatment of endogenous hypertriglyceridemia (type IV), a genetic disease characterized by elevated VLDL-TG concentration in plasma (26). Thus, weight loss alone can be effective in lowering plasma TO levels. In the present study, the subjects lost a similar amount of weight, 7.4 kg, but had increased plasma TG and decreased TC. Previous studies at lower altitudes have reported diverse effects on plasma lipid profiles (1, 10, 18, 25, 40) .
In the present study, we have demonstrated a significant increase in plasma TG similar to that of Whitten and Janoski during a 9-day altitude study on the summit of Pikes Peak (4300m) (40) . However, in that study, plasma TC levels were unchanged and fasting FFA increased approximately 2-fold (40). Also, there was a significant weight loss of 4.27 kg that the authors assume was solely body fat (40) . For the present study, data indicated that the weight loss was predominantly protein (29). In another study, following an 8-week climb between the altitudes of 4,000 and 7,130 m (465 Torr to 310 Torr), the concentration of plasma apolipoprotein A-I, the major protein of HDL, increased 2-fold but, the HDL cholesterol levels were not reported (25). In another short-term exposure to 3800m altitude, plasma TC was increased after 3-weeks (1). Long term residence has also been reported to alter cholesterol levels. Comparison of plasma cholesterol levels in socio-economically matched high (3500m) and lower (100m) altitude natives of Peru showed that the low altitude residents had higher total cholesterol levels, predominantly LDL-C (10). Aithouh the effects of altitude exposure on blood lipid profile are diverse, this may be the result of varying altitudes, duration of exposure, diet, and exercise.
During altitude studies, test subjects may assume a sedentary lifestyle that results in detraining (41) . In the present study, the subjects A significant hypolipemic response to exercise training in humans has been described (27), but the mechanism has not been elucidated. In the fasting state, the LPL activity of skeleta]l muscle is inversely related to the insulin:glucagon molar ratio (21) . Therefore increased plasma insulin concentration should depress LPL activity. In humans, glucagon excess has been reported to depress TG synthesis by the liver and reduce plasma TG accumulation (22) . Thus, the constant levels of glucagon seen in the fasting blood samples combined with increased insulin levels should result in increased hepatic production of TG-rich lipoproteins (4).
There is considerable evidence of an inverse relationship between the insulin:glucagon molar ratio and the need for endogenous energy production.
In the present study, the fasting insulin:glucagon molar ratio was lets than 1 and remained unchanged during the 40-day sojourn. This ratio has been reported to be indicative of total starvation or extreme physical exercise The effect of altitude on fasting plasma insulin concentrations. 
